Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-8722
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy ; volume:14 ; number:1 ; day:1 ; month:5 ; year:2021 ; pages:1-35 ; date:12.2021
Journal of hematology & oncology ; 14, Heft 1 (1.5.2021), 1-35, 12.2021
- Urheber
-
Gong, Ying
Klein Wolterink, Roel G. J.
Wang, Jianxiang
Bos, Gerard M. J.
Germeraad, Wilfred T. V.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13045-021-01083-5
- URN
-
urn:nbn:de:101:1-2021102222364229814347
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:20 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Gong, Ying
- Klein Wolterink, Roel G. J.
- Wang, Jianxiang
- Bos, Gerard M. J.
- Germeraad, Wilfred T. V.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Optimization of chimeric antigen receptor (CAR) therapy
Developing new chimeric antigen receptor (CAR)-engineered natural killer cells targeting ovarian cancer stem cells
The development and application of chimeric antigen receptor natural killer (CAR-NK) cells for cancer therapy: current state, challenges and emerging therapeutic advances
Anticancer traits of chimeric antigen receptors (CARs)-Natural Killer (NK) cells as novel approaches for melanoma treatment
Optimizations of anti-tumor efficacy during CD19-specific chimeric antigen receptor (CAR) T/NK-cell manufacturing
Chimeric antigen receptor engineered natural killer cells for cancer therapy
Chimeric antigen receptor-engineered natural killer cells for cancer immunotherapy
Chimeric antigen receptor (CAR)-engineered NK-92 cells : an off-the-shelf cellular therapeutic for universal tumor targeting
Chimeric antigen receptor (CAR)-modified natural killer cell-based immunotherapy and immunological synapse formation in cancer and HIV
Proteasome inhibition enhances the anti-leukemic efficacy of chimeric antigen receptor (CAR) expressing NK cells against acute myeloid leukemia
Chimeric antigen receptor (CAR)+ T cell selection method affects transgene efficacy
Management of chimeric antigen receptor T (CAR-T) cell-associated toxicities
Optimization of chimeric antigen receptor (CAR) therapy
Developing new chimeric antigen receptor (CAR)-engineered natural killer cells targeting ovarian cancer stem cells
The development and application of chimeric antigen receptor natural killer (CAR-NK) cells for cancer therapy: current state, challenges and emerging therapeutic advances
Anticancer traits of chimeric antigen receptors (CARs)-Natural Killer (NK) cells as novel approaches for melanoma treatment
Optimizations of anti-tumor efficacy during CD19-specific chimeric antigen receptor (CAR) T/NK-cell manufacturing
Chimeric antigen receptor engineered natural killer cells for cancer therapy
Chimeric antigen receptor-engineered natural killer cells for cancer immunotherapy
Chimeric antigen receptor (CAR)-engineered NK-92 cells : an off-the-shelf cellular therapeutic for universal tumor targeting
Chimeric antigen receptor (CAR)-modified natural killer cell-based immunotherapy and immunological synapse formation in cancer and HIV
Proteasome inhibition enhances the anti-leukemic efficacy of chimeric antigen receptor (CAR) expressing NK cells against acute myeloid leukemia
Chimeric antigen receptor (CAR)+ T cell selection method affects transgene efficacy
Management of chimeric antigen receptor T (CAR-T) cell-associated toxicities
Optimization of chimeric antigen receptor (CAR) therapy
Developing new chimeric antigen receptor (CAR)-engineered natural killer cells targeting ovarian cancer stem cells
The development and application of chimeric antigen receptor natural killer (CAR-NK) cells for cancer therapy: current state, challenges and emerging therapeutic advances
Anticancer traits of chimeric antigen receptors (CARs)-Natural Killer (NK) cells as novel approaches for melanoma treatment
Optimizations of anti-tumor efficacy during CD19-specific chimeric antigen receptor (CAR) T/NK-cell manufacturing
Chimeric antigen receptor engineered natural killer cells for cancer therapy
Chimeric antigen receptor-engineered natural killer cells for cancer immunotherapy
Chimeric antigen receptor (CAR)-engineered NK-92 cells : an off-the-shelf cellular therapeutic for universal tumor targeting
Chimeric antigen receptor (CAR)-modified natural killer cell-based immunotherapy and immunological synapse formation in cancer and HIV
Proteasome inhibition enhances the anti-leukemic efficacy of chimeric antigen receptor (CAR) expressing NK cells against acute myeloid leukemia
Chimeric antigen receptor (CAR)+ T cell selection method affects transgene efficacy